IQP-PO-101 for the Regulation of Bowel Movement Frequency

NCT01809587 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

InQpharm Group